Ehrlichiosis classification: Difference between revisions
Jump to navigation
Jump to search
m (Changes made per Mahshid's request) |
|||
| (13 intermediate revisions by one other user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{IMD}} | {{CMG}} {{AE}} {{IMD}} | ||
==Overview== | ==Overview== | ||
Four species (''E. ewingii, E. chaffeensis, E. Muris'', and ''A. phagocytophilum'') are responsible for human ehrlichiosis infections. ehrlichiosis infections present themselves with very similar, if not the same, clinical manifestations. Differences may be highlighted in the heightened fatality rate and neurological based clinical manifestations of HME versus other types of ehrlichiosis. Endemic regions are different among the different diseases which may be used to diagnose the organism of infection.<ref name="E Sym">Ehrlichiosis Symptoms. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/ehrlichiosis/symptoms/index.html Accessed on December 30, 2015</ref> | |||
== | ==Classification== | ||
* Ehrlichiosis is a broadly used medical term for multiple bacterial infections. | * Ehrlichiosis is a broadly used medical term for multiple bacterial infections. | ||
* | * Four species have been identified in human ehrlichiosis infections (each disease is associated with a specific bacterial strain): | ||
# ''Ehrlichia | # ''Ehrlichia ewingii'' | ||
# ''Ehrlichia | # ''Ehrlichia chaffeensis'' | ||
# ''Ehrlichia | # ''Ehrlichia muris''<ref name="“HML">Human Infection with Ehrlichia muris–like Pathogen, United States, 2007–2013. Diep K. Hoang Johnson2, Elizabeth Schiffman2, Jeffrey P. Davis, David Neitzel, Lynne M. Sloan, William L. Nicholson, Thomas R. Fritsche, Christopher R. Steward, Julie A. Ray, Tracy K. Miller, Michelle A. Feist, Timothy S. Uphoff, Joni J. Franson, Amy L. Livermore, Alecia K. Deedon, Elitza S. Theel, and Bobbi S. Prit. http://wwwnc.cdc.gov/eid/article/21/10/15-0143_article Accessed January 13, 2016. </ref> | ||
# ''Anaplasma phagocytophilum'' | |||
*Infections with the above organism have similar or the same clinical presentation. | |||
*HME however has proven to be more fatal than other Ehrlichia infections, including CNS and neurological disorders inflicting nearly 20% of all infected patients. | |||
{| style="font-size: 85%;" | {| style="font-size: 85%;" | ||
| Line 22: | Line 23: | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | ''[[Ehrlichia ewingii]]'' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | ''[[Ehrlichia ewingii]]'' | ||
| style="background: #DCDCDC; padding: 5px;" | | | style="background: #DCDCDC; padding: 5px;" |Human ehrlichiosis ewingii (HEE) | ||
| style="background: #DCDCDC; padding: 5px;" | | | style="background: #DCDCDC; padding: 5px;" |Lone Star Tick (''Amblyomma americanum'') | ||
| style="background: #DCDCDC; padding: 5px;" |Southeastern and South Central United States | | style="background: #DCDCDC; padding: 5px;" |Southeastern and South Central United States | ||
| style="background: #DCDCDC; padding: 5px;" | | | style="background: #DCDCDC; padding: 5px;" | Similar symptoms to those of HME and HGA. Although not much has been documented due to the minor amount of reported cases. | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | ''[[Ehrlichia chaffeensis]]'' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | ''[[Ehrlichia chaffeensis]]'' | ||
| style="background: #DCDCDC; padding: 5px;" |Ehrlichiosis | | style="background: #DCDCDC; padding: 5px;" |Human Monocytotropic Ehrlichiosis | ||
| style="background: #DCDCDC; padding: 5px;" | | | style="background: #DCDCDC; padding: 5px;" |Lone Star Tick (''Amblyomma americanum'') | ||
| style="background: #DCDCDC; padding: 5px;" | | | style="background: #DCDCDC; padding: 5px;" |Mississippi, Tennessee, Arkansas, and Maryland. South central and Southeastern United States. | ||
| style="background: #DCDCDC; padding: 5px;" | | | style="background: #DCDCDC; padding: 5px;" |More Severe than HGA and HEE. Clinical manifestations include gastrointestinal symptoms, headaches, myalgias, and arthralgias. It's been documented that 20% of infected patients have neurological manifestations, CNS complications, potential seizures and coma. Potential rash, however the rash may indicate a co-infection between [[Rocky Mountain Spotted Fever]] and Ehrlichiosis. | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | ''[[Ehrlichia canis|Ehrlichia muris]]'' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | ''[[Ehrlichia canis|Ehrlichia muris]]'' | ||
| style="background: #DCDCDC; padding: 5px;" |Ehrlichiosis | | style="background: #DCDCDC; padding: 5px;" |Ehrlichiosis muris-like (EML) | ||
| style="background: #DCDCDC; padding: 5px;" | Not yet established | | style="background: #DCDCDC; padding: 5px;" | Not yet established | ||
| style="background: #DCDCDC; padding: 5px;" |Minnesota and Wisconsin | | style="background: #DCDCDC; padding: 5px;" |Minnesota and Wisconsin | ||
| style="background: #DCDCDC; padding: 5px;" | | | style="background: #DCDCDC; padding: 5px;" |Common symptoms include fever, malaise, thrombocytopenia, and lymphopenia. | ||
|}<ref name="E Sym">Ehrlichiosis Symptoms. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/ehrlichiosis/symptoms/index.html Accessed on December 30, 2015</ref> | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | ''[[Anaplasma phagocytophilum]]'' | |||
| style="background: #DCDCDC; padding: 5px;" |Human Granulocytotropic Anaplasmosis | |||
| style="background: #DCDCDC; padding: 5px;" |Black-legged Tick (''Ixodes scapularis'') | |||
| style="background: #DCDCDC; padding: 5px;" |Occurs worldwide (including portions of Europe and Asia.) | |||
| style="background: #DCDCDC; padding: 5px;" |Fever, headache, and myalgias. Rash is uncommon, and CNS disorders as well as neurological issues have been reported in less than 1%. | |||
|}<ref name="E Sym">Ehrlichiosis Symptoms. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/ehrlichiosis/symptoms/index.html Accessed on December 30, 2015</ref><ref name="“HEA">Human Ehrlichiosis and Anaplasmosis. Ismail N, Bloch KC, Mcbride JW. Human ehrlichiosis and anaplasmosis. Clin Lab Med. 2010;30(1):261-92. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882064/ Accessed January 13, 2016. </ref><ref name="“HML">Human Infection with Ehrlichia muris–like Pathogen, United States, 2007–2013. Diep K. Hoang Johnson2, Elizabeth Schiffman2, Jeffrey P. Davis, David Neitzel, Lynne M. Sloan, William L. Nicholson, Thomas R. Fritsche, Christopher R. Steward, Julie A. Ray, Tracy K. Miller, Michelle A. Feist, Timothy S. Uphoff, Joni J. Franson, Amy L. Livermore, Alecia K. Deedon, Elitza S. Theel, and Bobbi S. Prit. http://wwwnc.cdc.gov/eid/article/21/10/15-0143_article Accessed January 13, 2016.</ref> | |||
==References== | ==References== | ||
| Line 44: | Line 51: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 17:38, 18 September 2017
|
Ehrlichiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ehrlichiosis classification On the Web |
|
American Roentgen Ray Society Images of Ehrlichiosis classification |
|
Risk calculators and risk factors for Ehrlichiosis classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ilan Dock, B.S.
Overview
Four species (E. ewingii, E. chaffeensis, E. Muris, and A. phagocytophilum) are responsible for human ehrlichiosis infections. ehrlichiosis infections present themselves with very similar, if not the same, clinical manifestations. Differences may be highlighted in the heightened fatality rate and neurological based clinical manifestations of HME versus other types of ehrlichiosis. Endemic regions are different among the different diseases which may be used to diagnose the organism of infection.[1]
Classification
- Ehrlichiosis is a broadly used medical term for multiple bacterial infections.
- Four species have been identified in human ehrlichiosis infections (each disease is associated with a specific bacterial strain):
- Ehrlichia ewingii
- Ehrlichia chaffeensis
- Ehrlichia muris[2]
- Anaplasma phagocytophilum
- Infections with the above organism have similar or the same clinical presentation.
- HME however has proven to be more fatal than other Ehrlichia infections, including CNS and neurological disorders inflicting nearly 20% of all infected patients.
| Organism | Disease | Vector | Endemic Regions | Common Symptoms |
|---|---|---|---|---|
| Ehrlichia ewingii | Human ehrlichiosis ewingii (HEE) | Lone Star Tick (Amblyomma americanum) | Southeastern and South Central United States | Similar symptoms to those of HME and HGA. Although not much has been documented due to the minor amount of reported cases. |
| Ehrlichia chaffeensis | Human Monocytotropic Ehrlichiosis | Lone Star Tick (Amblyomma americanum) | Mississippi, Tennessee, Arkansas, and Maryland. South central and Southeastern United States. | More Severe than HGA and HEE. Clinical manifestations include gastrointestinal symptoms, headaches, myalgias, and arthralgias. It's been documented that 20% of infected patients have neurological manifestations, CNS complications, potential seizures and coma. Potential rash, however the rash may indicate a co-infection between Rocky Mountain Spotted Fever and Ehrlichiosis. |
| Ehrlichia muris | Ehrlichiosis muris-like (EML) | Not yet established | Minnesota and Wisconsin | Common symptoms include fever, malaise, thrombocytopenia, and lymphopenia. |
| Anaplasma phagocytophilum | Human Granulocytotropic Anaplasmosis | Black-legged Tick (Ixodes scapularis) | Occurs worldwide (including portions of Europe and Asia.) | Fever, headache, and myalgias. Rash is uncommon, and CNS disorders as well as neurological issues have been reported in less than 1%. |
References
- ↑ 1.0 1.1 Ehrlichiosis Symptoms. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/ehrlichiosis/symptoms/index.html Accessed on December 30, 2015
- ↑ 2.0 2.1 Human Infection with Ehrlichia muris–like Pathogen, United States, 2007–2013. Diep K. Hoang Johnson2, Elizabeth Schiffman2, Jeffrey P. Davis, David Neitzel, Lynne M. Sloan, William L. Nicholson, Thomas R. Fritsche, Christopher R. Steward, Julie A. Ray, Tracy K. Miller, Michelle A. Feist, Timothy S. Uphoff, Joni J. Franson, Amy L. Livermore, Alecia K. Deedon, Elitza S. Theel, and Bobbi S. Prit. http://wwwnc.cdc.gov/eid/article/21/10/15-0143_article Accessed January 13, 2016.
- ↑ Human Ehrlichiosis and Anaplasmosis. Ismail N, Bloch KC, Mcbride JW. Human ehrlichiosis and anaplasmosis. Clin Lab Med. 2010;30(1):261-92. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882064/ Accessed January 13, 2016.